Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Cell Point (India)'s share price for the quarter that ended in Mar. 2026 was ₹12. Cell Point (India)'s Shares Outstanding (EOP) for the quarter that ended in Mar. 2026 was 19 Mil. Therefore, Cell Point (India)'s market cap for the quarter that ended in Mar. 2026 was ₹225 Mil.
Cell Point (India)'s quarterly market cap
increased
from Mar. 2025 (₹298 Mil) to Sep. 2025 (₹340 Mil) but then
declined
from Sep. 2025 (₹340 Mil) to Mar. 2026 (₹225 Mil).
Cell Point (India)'s annual market cap
declined
from Mar. 2024 (₹601 Mil) to Mar. 2025 (₹298 Mil) and
declined
from Mar. 2025 (₹298 Mil) to Mar. 2026 (₹224 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Cell Point (India)'s Enterprise Value for Today is ₹992 Mil.
Cell Point (India) (NSE:CELLPOINT) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Cell Point (India) Market Cap Related Terms
Cell Point (India) Market Cap Historical Data
* Premium members only.
The historical data trend for Cell Point (India)'s Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
NSE:CELLPOINT vs CASY, WSM, ULTA: Market Cap Comparison
For the Specialty Retail subindustry, Cell Point (India)'s Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Cell Point (India) Market Cap vs Retail - Cyclical Industry
For the Retail - Cyclical industry and Consumer Cyclical sector, Cell Point (India)'s Market Cap distribution charts can be found below:
* The bar in red indicates where Cell Point (India)'s Market Cap falls into.
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
Cell Point (India)'s Market Cap for the fiscal year that ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Cell Point (India) (NSE:CELLPOINT) has a Market Cap of ₹280 Mil as of Jun. 28, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Cell Point (India) and its competitors. According to the industry distribution chart, Cell Point (India) ranks #1094 out of 1137 companies in the Retail - Cyclical industry, placing it in the top 96.2%.
Is Cell Point (India)'s Market Cap too high?
Cell Point (India)'s current Market Cap is ₹280 Mil. Based on the distribution chart, Cell Point (India) ranks #1094 out of 1137 companies in the Retail - Cyclical industry, which is in the bottom quartile relative to peers. Overall, Cell Point (India) has a GF Score™ of 71/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Cell Point (India)'s Market Cap compare to CASY and WSM?
According to the Retail - Cyclical industry distribution chart, Cell Point (India) ranks #1094 out of 1137 companies for Market Cap. This places Cell Point (India) in the lower half of its industry. The industry median Market Cap is 144.25. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Retail - Cyclical company?
The median Market Cap among Retail - Cyclical companies is 144.25, based on 1,137 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Cell Point (India) and its competitors. For the Retail - Cyclical industry, the median Market Cap is 144.25 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Cell Point (India)'s current Market Cap is ₹280 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cell Point (India) stock overvalued right now?
Based on GuruFocus' analysis, Cell Point (India) (NSE:CELLPOINT) is currently considered Significantly Undervalued. The stock's GF Value™ is ₹34.72, compared to a current price of ₹15.00 — trading 56.8% below its estimated fair value. The current Market Cap is ₹280 Mil. Cell Point (India)'s overall GF Score™ is 71/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For Cell Point (India) (NSE:CELLPOINT), the current Market Cap is ₹280 Mil as of Jun. 28, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Cell Point (India) (NSE:CELLPOINT) Overvalued in 2026?
Based on GuruFocus' analysis, Cell Point (India) stock appears to be undervalued.
The current stock price of ₹15.00 is trading 56.8% below its estimated GF Value™ of ₹34.72.
GuruFocus considers Cell Point (India) to be Significantly Undervalued.
Key valuation signals for NSE:CELLPOINT:
Market Cap: ₹280 Mil
GF Value™: ₹34.72 vs. price of ₹15.00 (56.8% below fair value)
No single metric tells the full story. See the NSE:CELLPOINT stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Cell Point (India) Ltd is engaged in multi-brand retail selling of smartphones, tablets, mobile accessories, and mobile-related products of various brands such as Apple, Samsung, Oppo, Realme, Nokia, Vivo, Xiaomi, Nokia, Redmi, Techno, One Plus, etc. It is also engaged in retail selling of consumer durable electronics goods, smart televisions, smart watches, and air conditioners of various brands such as Xiaomi, Realme, and One Plus among others. The company operates in a single segment and derives revenue from its operations in India.
71GF Score
Get the complete analysis for NSE:CELLPOINT
Market Cap is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:CELLPOINT has been successfully added to your 
